The leading representative office of defined Corporate Investor is situated in the Paris. The company was established in Europe in France.
Among the most popular portfolio startups of the fund, we may highlight Ekinops, Univa, Genkyotex. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Pharmaceutical, Therapeutics. The fund has exact preference in some founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. For fund there is a match between the location of its establishment and the land of its numerous investments - France.
Besides them, we counted 3 critical employees of this fund in our database.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Societe Generale Asset Management, startups are often financed by Auriga Partners, Ventech, Partech. The meaningful sponsors for the fund in investment in the same round are Omnes Capital, Auriga Partners, Partech. In the next rounds fund is usually obtained by Amundi Private Equity Funds, ODYSSEE VENTURE, Ventech.
The fund is constantly included in 2-6 deals per year. The real fund results show that this Corporate Investor is 11 percentage points less often commits exit comparing to other companies. The common things for fund are deals in the range of 10 - 50 millions dollars. Comparing to the other companies, this Societe Generale Asset Management performs on 9 percentage points more the average number of lead investments. The top amount of exits for fund were in 2012. When the investment is from Societe Generale Asset Management the average startup value is 10-50 millions dollars. The top activity for fund was in 2006.
Related Funds
Funds with similar focus
Fund Name | Location |
AION Capital Partners | India, Maharashtra, Mumbai |
Alco Investment | Geneva, Geneve, Switzerland |
Arthur Rock & Associates | - |
Bancoldex | - |
Cadence Growth Capital | Bayern, Germany, Grünwald |
Eficor Ventures | Finland, Helsinki, Southern Finland |
General Secretariat for Research and Technology (GSRT) | - |
Gleneagles Securities | - |
HIX Capital | Brazil, São Paulo, Sao Paulo |
Inception Capital | Community of Madrid, Madrid, Spain |
Meituan.com | Beijing, Beijing, China |
NMA Ventures | Albuquerque, New Mexico, United States |
Opera Tech Ventures | France, Ile-de-France, Paris |
Reflective Venture Partners | Seattle, United States, Washington |
RiskEx LLC | - |
Shanxi Qin Niongjiuye | China, Shaanxi, Xian Shi |
Tech Coast Angels San Diego | California, San Diego, United States |
The Kiyo Bank | Japan, Wakayama, Wakayama Prefecture |
The Sterling Group | Houston, Texas, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Force-A | $2M | 09 Nov 2009 | Ile-de-France | ||
Genomic Vision | $4M | 25 Jul 2008 | Ile-de-France | ||
Genkyotex | $4M | 05 May 2008 | Geneva, Switzerland | ||
Jobpartners | $12M | 01 Apr 2008 | London, England, United Kingdom | ||
Ekinops | $20M | 01 Oct 2007 | France, Brittany, France | ||
GQ Life Sciences | $4M | 24 Sep 2007 | Boston, Massachusetts, United States | ||
Force-A | $3M | 26 Mar 2007 | Ile-de-France | ||
Sequans Communications | $24M | 22 Oct 2006 | Ile-de-France | ||
Infront Analytics | $2M | 13 Oct 2006 | Ile-de-France |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Force-A | $2M | 09 Nov 2009 | Ile-de-France | ||
Genomic Vision | $4M | 25 Jul 2008 | Ile-de-France | ||
Genkyotex | $4M | 05 May 2008 | Geneva, Switzerland | ||
Jobpartners | $12M | 01 Apr 2008 | London, England, United Kingdom | ||
Ekinops | $20M | 01 Oct 2007 | France, Brittany, France | ||
GQ Life Sciences | $4M | 24 Sep 2007 | Boston, Massachusetts, United States | ||
Force-A | $3M | 26 Mar 2007 | Ile-de-France | ||
Sequans Communications | $24M | 22 Oct 2006 | Ile-de-France | ||
Infront Analytics | $2M | 13 Oct 2006 | Ile-de-France |